Parexel launches dedicated biotech division

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Pattanaphong Khuankaew)
(Image: Getty/Pattanaphong Khuankaew)

Related tags: Parexel, Parexel Biotech

Parexel Biotech will support emerging companies from development through commercialization with tailored services and customized guidance, says division lead.

The division – Parexel Biotech – offers a new biotech-focused team and organizational structure for customers, and will be led by James Anthony, global head of biotech, and Graciela Racaro, global head of biotech operations.

“Parexel understands that emerging biotech companies have different needs and require a different style of service than large, established pharmaceutical companies, and will be able to provide these companies with tailored, customized guidance to meet those specific needs,”​ Anthony told Outsourcing-Pharma.

The contract research organization (CRO) has worked with biotech companies for several years, but the new division now provides a dedicated team focused on the needs of emerging companies, he added.

“Emerging biotech customers serve as the innovative arm of the industry, driving new therapies forward for development with the ultimate goal of market approval,” ​said Anthony – and the CRO's percentage of its overall business sponsored by this market segment has grown significantly over the past decade.

Parexel Biotech’s offering will include regulatory and strategic consulting, the ability to recruit patients and conduct trials, generation of real-world evidence (RWE) leveraging internal expertise and partnerships, such as with Datavant and SHYFT Analytics, among others.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars